by Clare Gerrard | Oct 12, 2022
NHS Genomics Strategy launched today at #NHSGenomics2022 by @AmandaPritchard It sets out our ambitions over the next 5-10 years to harness the potential of genomics to transform patient care. https://www.england.nhs.uk/genomics/genomics-strategy/
by Leanne Talbot | Oct 26, 2021
Monday 25th October saw the launch of the NHS Cancer Quality of Life Survey data dashboard. The survey is for people in England who have been diagnosed with cancer. From 2020, people who have had a breast, prostate or colorectal (bowel) cancer diagnosis are being...
by Leanne Talbot | Apr 21, 2021
Genomics : PART ONE : 100,000 Genomes Project – and beyond! In late 2012, the then Prime Minister, David Cameron, announced the 100,000 Genomes Project. Its four main aims were; to enable new scientific discovery and medical insights to bring benefit to...
by Leanne Talbot | Apr 21, 2021
21st APRIL NICE APPROVES AVELUMAB Neuroendocrine Cancer UK is delighted to share with you NICE’s approval of Avelumab as a first line therapy option in metastatic MCC. Avelumab is now recommended as an option for treating metastatic Merkel cell carcinoma in adults...
by Leanne Talbot | Apr 19, 2021
Public Health England (PHE), NHS England and NHS Improvement (NHSE&I) have launched a nationwide Cancer Quality of Life Survey to find out how quality of life may have changed for people diagnosed with cancer. The information collected from the survey will help us...
